Verrica Pharmaceuticals Inc.
VRCA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660334
In the last 90 days, Verrica Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $28.5M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Verrica Pharmaceuticals Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +4 vs. Q1 2026
- Shares held
- 4.66M
- −115.2K (−2.4%) vs. Q1 2026
- Total value
- $28.5M
- +$3.26M (+12.9%) vs. Q1 2026
- New holders
- 9
- 7 more added
- Sold out
- 5
- 11 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRCA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 43 | $28.5M |
| Q1 2026 | 39 | $25.3M |
| Q4 2025 | 50 | $43.2M |
| Q3 2025 | 34 | $10.6M |
| Q2 2025 | 59 | $13.4M |
| Q1 2025 | 75 | $13.0M |
| Q4 2024 | 81 | $21.0M |
| Q3 2024 | 79 | $21.6M |
| Q2 2024 | 74 | $135.9M |
| Q1 2024 | 62 | $105.1M |
| Q4 2023 | 64 | $131.8M |
| Q3 2023 | 67 | $58.5M |
| Q2 2023 | 63 | $84.2M |
| Q1 2023 | 60 | $84.2M |
| Q4 2022 | 50 | $29.8M |
| Q3 2022 | 49 | $29.9M |
| Q2 2022 | 57 | $21.8M |
| Q1 2022 | 51 | $72.1M |
| Q4 2021 | 45 | $82.0M |
| Q3 2021 | 49 | $114.6M |
| Q2 2021 | 53 | $112.3M |
| Q1 2021 | 51 | $150.4M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Verrica Pharmaceuticals Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Valley National Advisers Inc | 25 | $153 | 0.00% | +25 | New |
| Jones Financial Companies LLLP | 26 | $178 | 0.00% | 00.0% | Unchanged |
| Ameritas Advisory Services, LLC | 30 | $184 | 0.00% | +30 | New |
| JPMorgan Chase & Co | 47 | $306 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 64 | $392 | 0.00% | +64 | New |
| The PNC Financial Services Group, Inc. | 102 | $624 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 110 | $673 | 0.00% | 00.0% | Unchanged |
| Fortitude Family Office, LLC | 127 | $777 | 0.00% | 00.0% | Unchanged |
| International Assets Investment Management, LLC | 175 | $1.04K | 0.00% | 00.0% | Unchanged |
| New England Capital Financial Advisors LLC | 200 | $1.22K | 0.00% | 00.0% | Unchanged |
| Allied Private Wealth LLC | 202 | $1.34K | 0.00% | +202 | New |
| Salomon & Ludwin, LLC | 290 | $1.72K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 614 | $3.76K | 0.00% | −242−28.3% | Reduced |
| Royal Bank of Canada | 764 | $5.00K | 0.00% | −201−20.8% | Reduced |
| Vanguard Global Advisers, LLC | 862 | $5.28K | 0.00% | 00.0% | Unchanged |
| Capital Analysts, LLC | 1,500 | $9.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 3,201 | $19.6K | 0.00% | −19,185−85.7% | Reduced |
| UBS Group AG | 6,071 | $37.2K | 0.00% | +1,801+42.2% | Added |
| Beck Mack & Oliver LLC | 12,000 | $73.4K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 13,023 | $79.0K | 0.00% | +13,023 | New |
| Two Sigma Securities, LLC | 13,045 | $79.8K | 0.01% | +13,045 | New |
| XTX Topco Ltd | 13,723 | $84.0K | 0.00% | +13,723 | New |
| Dimensional Fund Advisors LP | 13,888 | $85.0K | 0.00% | +13,888 | New |
| Fifth Third Bancorp | 14,000 | $85.7K | 0.00% | +14,000 | New |
| Legacy Trust | 16,584 | $101.5K | 0.02% | −650−3.8% | Reduced |
| Renaissance Technologies LLC | 21,769 | $133.2K | 0.00% | −10,591−32.7% | Reduced |
| Verdad Advisers, LP | 23,069 | $141.2K | 0.14% | +10,971+90.7% | Added |
| Jane Street Group, LLC | 23,654 | $144.8K | 0.00% | −25,557−51.9% | Reduced |
| DAFNA Capital Management LLC | 23,750 | $145.3K | 0.03% | −129,962−84.5% | Reduced |
| Northern Trust Corp | 26,996 | $165.2K | 0.00% | −4,584−14.5% | Reduced |
| State Street Corp | 28,916 | $177.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 40,825 | $249.8K | 0.00% | −9,837−19.4% | Reduced |
| Vanguard Fiduciary Trust Co | 70,173 | $429.5K | 0.00% | +5,072+7.8% | Added |
| BlackRock, Inc. | 74,344 | $455.0K | 0.00% | +35,791+92.8% | Added |
| Geode Capital Management, LLC | 138,160 | $845.7K | 0.00% | −757−0.5% | Reduced |
| Mariner, LLC | 207,230 | $1.27M | 0.00% | +182,686+744.3% | Added |
| Vanguard Capital Management LLC | 279,310 | $1.71M | 0.00% | +90,552+48.0% | Added |
| Boothbay Fund Management, LLC | 280,734 | $1.72M | 0.03% | 00.0% | Unchanged |
| Armistice Capital, LLC | 426,304 | $2.61M | 0.07% | −91,877−17.7% | Reduced |
| Velan Capital Investment Management LP | 471,559 | $2.89M | 1.77% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 707,338 | $4.33M | 0.21% | 00.0% | Unchanged |
| Cannell Capital LLC | 783,923 | $4.80M | 3.35% | +98,800+14.4% | Added |
| Caligan Partners LP | 923,910 | $5.65M | 0.27% | 00.0% | Unchanged |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −140,497−100.0% | Sold out |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −99,735−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −75,208−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −2−100.0% | Sold out |